Cellular Redox Homeostasis and Ageing

What Redox Homeostasis Means

Reduction and oxidation describe the transfer of electrons. In cells, these reactions connect energy metabolism to the reversible modification of proteins and to defence against molecular damage. Redox homeostasis is therefore a dynamic, regulated state: cells generate oxidants, sense them, use some as signals, and constrain or repair their effects. It is more accurate to think of coordinated redox networks than of a single balance between “oxidants” and “antioxidants.” [2] [3]

Who This Is Useful For

This page is intended for readers who want to understand how oxidative stress fits into modern ageing biology. It distinguishes physiological redox signalling from oxidative damage and explains why a measurement of one oxidant, antioxidant, or oxidation product cannot by itself describe the redox state of an entire cell, tissue, or organism. [1] [2]

The Main Components

These systems are coupled. NADPH supplies electrons used to restore reduced glutathione and thioredoxin, while peroxiredoxins, glutathione peroxidases, catalase, and other enzymes control particular reactive species in particular locations. NRF2 regulates many genes involved in glutathione synthesis, thioredoxin metabolism, detoxification, and NADPH production. [2] [4] [5]

Signalling and Damage Are Different Outcomes

Reactive oxygen species are normal products and regulators of aerobic biology. At controlled levels, hydrogen peroxide can reversibly modify susceptible cysteine residues on proteins, changing enzyme or signalling activity. The biological result depends on the reactive species, its concentration, where it is produced, how long it persists, and which molecular targets are nearby. [1] [3]

Oxidative distress occurs when oxidant formation and exposure exceed the capacity for controlled signalling, prevention, and repair. Under those conditions, oxidation can become less selective and contribute to protein dysfunction, membrane-lipid oxidation, and nucleic-acid damage. This is not simply the opposite of signalling: the two states can involve some of the same molecules at different doses, durations, or cellular locations. [1] [7]

How Redox Regulation Can Change with Age

Age-related redox change can arise on both sides of the system. Mitochondria, NADPH oxidases, peroxisomes, and other enzymes can alter oxidant production, while repair and reducing systems can lose capacity or become less responsive. In experimental studies, the glutathione redox couple often shifts in a more oxidizing direction with age, although the magnitude differs among tissues and does not occur uniformly. [4] [6]

The adaptive response matters as much as the baseline state. Young and old cells may have similar resting measurements yet differ in how quickly they induce protective enzymes or recover after a challenge. Reviews of NRF2 ageing research report reduced pathway activity or inducibility in many models, alongside substantial variation by tissue, species, sex, and study design. [4] [5]

Mitochondria and Metabolic Context

Mitochondria are one source of cellular oxidants, but their role cannot be reduced to accidental leakage from respiration. Mitochondrial reactive oxygen species can participate in regulated responses to oxygen availability, metabolism, inflammation, and cell fate. Age-related changes in mitochondrial function can therefore influence both oxidative damage and redox communication with the rest of the cell. [3] [8]

Reducing capacity is also metabolic. NADPH is generated by several pathways and used to recycle glutathione and thioredoxin. Changes in nutrient use, mitochondrial activity, and enzyme expression can alter this supply. Redox homeostasis is consequently linked to metabolism and organelle quality control, rather than operating as a separate antioxidant layer. [2] [7]

Connections to Other Ageing Processes

Redox disruption can intersect with proteostasis, genomic maintenance, cellular senescence, inflammation, and stem-cell function. Oxidation can affect protein folding and degradation, DNA damage responses, inflammatory signalling, and the maintenance of redox-sensitive stem-cell states. In turn, dysfunctional mitochondria, chronic inflammation, and impaired proteostasis can change redox conditions, creating feedback rather than a simple one-way chain. [3] [5] [8]

Evidence Quality and Open Questions

Evidence is strong that controlled redox signalling is required for normal cellular function and that excessive oxidation can damage biomolecules. There is also substantial evidence from cultured cells, model organisms, and ageing tissues that glutathione state, NRF2 responses, mitochondrial oxidant handling, and oxidative damage can change with age. [1] [4] [6]

Evidence is less decisive about causal order and generality in normal human ageing. An oxidized marker may be a driver, a consequence, a compensatory response, or a mixture of these. Many measurements average across cells or compartments, even though redox reactions are localized and short-lived. This makes it difficult to infer a whole redox network from a single blood marker, tissue sample, or antioxidant-enzyme measurement. [1] [2] [9]

The older free-radical theory helped establish oxidative damage as an ageing research question, but contemporary models are broader. They incorporate physiological oxidant signalling, multiple redox couples, compartmentalization, adaptive responses, and reciprocal interactions with other hallmarks of ageing. Redox imbalance is therefore best treated as one connected dimension of ageing biology rather than a complete explanation by itself. [3] [7] [8]

What This Does Not Mean

• Reactive oxygen species are not uniformly harmful; controlled amounts have normal signalling functions. [1] [3]
• “More antioxidant” is not equivalent to better redox regulation, because indiscriminate removal of oxidants can disrupt signalling and has not reliably translated into clinical benefit. [1] [9]
• A higher level of one oxidation marker does not identify its source, cellular location, causal role, or the state of every redox pathway. [2] [7]
• Age-related redox changes do not occur identically in every tissue, species, or experimental model. [4] [6]

Summary

Cellular redox homeostasis is a distributed control system linking metabolism, oxidant production, antioxidant and repair enzymes, and redox-sensitive signalling. Ageing can alter several parts of this system, including glutathione metabolism, thioredoxin-dependent reduction, NRF2 responses, and mitochondrial signalling. The most defensible interpretation is not that oxidation alone causes ageing, but that declining redox control can both influence and reflect wider changes in cellular maintenance. [2] [4] [8]

References

1. Sies, H., and Jones, D. P. (2020). “Reactive oxygen species (ROS) as pleiotropic physiological signalling agents.” Nature Reviews Molecular Cell Biology. https://www.nature.com/articles/s41580-020-0230-3
2. Jones, D. P., and Sies, H. (2015). “The redox code.” Antioxidants & Redox Signaling. https://pmc.ncbi.nlm.nih.gov/articles/PMC4550464/
3. Holmström, K. M., and Finkel, T. (2014). “Cellular mechanisms and physiological consequences of redox-dependent signalling.” Nature Reviews Molecular Cell Biology. https://www.nature.com/articles/nrm3801
4. Zhang, H., Davies, K. J. A., and Forman, H. J. (2015). “Oxidative stress response and Nrf2 signaling in aging.” Free Radical Biology and Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC4628850/
5. Dodson, M., et al. (2019). “Redox regulation by NRF2 in aging and disease.” Free Radical Biology and Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC6588470/
6. Rebrin, I., and Sohal, R. S. (2008). “Pro-oxidant shift in glutathione redox state during aging.” Advanced Drug Delivery Reviews. https://pubmed.ncbi.nlm.nih.gov/18652861/
7. Sies, H., Berndt, C., and Jones, D. P. (2017). “Oxidative stress.” Annual Review of Biochemistry. https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-061516-045037
8. López-Otín, C., et al. (2023). “Hallmarks of aging: An expanding universe.” Cell. https://pmc.ncbi.nlm.nih.gov/articles/PMC10809922/
9. Forman, H. J., and Zhang, H. (2021). “Targeting oxidative stress in disease: promise and limitations of antioxidant therapy.” Nature Reviews Drug Discovery. https://www.nature.com/articles/s41573-021-00233-1